A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/9708950

Cancer 1998 Aug 15 83 4 813-6

Download in:

View as

Triples

General Info

PMID
9708950